NSE · ALIVUS
Alivus Life Sciences Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#413
of 5,072 stocks
▼ 71W
Peak #406 · 21 Sep 2026
Alivus Life Sciences Limited is a midcap company in the Healthcare space and remains firmly promoter-controlled, with promoters holding 75%, is growing revenue modestly, and commands a premium earnings multiple.
Market Cap
16,761.37 Cr
P/E Ratio
29.26
P/B Ratio
4.96
ROE
16.94%
ROCE
22.51%
Dividend Yield
0.37%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 640.41 Cr | 689.12 Cr | 672.89 Cr | 587.98 Cr |
| Net Profit | 160.08 Cr | 162.66 Cr | 150.26 Cr | 130.03 Cr |
| EPS | 13.04 | 13.23 | 12.25 | 10.60 |
| Operating Profit | 213.53 Cr | 217.11 Cr | 225.54 Cr | 175.46 Cr |
Shareholding pattern
Promoter
74.87%
Public
25.13%
PUBLIC BREAKDOWN
FII
5.54%
DII
7.18%
MF (within DII)
5.65%
Individuals
10.74%
Mutual fund holdings
₹759.49
Cr total
13
Schemes
9
Fund Houses
₹759.49 Cr
Total Exposure
Quant Mutual Fund₹500.34 Cr (65.9%)
Bandhan Mutual Fund₹127.73 Cr (16.8%)
ICICI Prudential Mutual Fund₹84.68 Cr (11.1%)
Helios Mutual Fund₹17.78 Cr (2.3%)
Motilal Oswal Mutual Fund₹11.38 Cr (1.5%)
Others₹17.58 Cr (2.3%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 01 Sep 2026 | Dividend | Dividend - Rs 5 Per Share |
| 01 Sep 2025 | Dividend | Dividend - Rs 5 Per Share |
| 17 Oct 2023 | Dividend | Interim Dividend - Rs 22.50 Per Share |
| 22 Sep 2023 | Other | Annual General Meeting |
| 24 Mar 2023 | Dividend | Interim Dividend - Rs 21 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.